Assembly Biosciences (ASMB) Revenue (2017 - 2026)

Assembly Biosciences' Revenue history runs 9 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• In Q1 2026, Revenue fell 12.8% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $71.1 million (up 121.11% YoY), while the FY2025 annual figure was $72.3 million, up 153.52% from the prior year.
• Revenue was $8.2 million for Q1 2026 at Assembly Biosciences, down from $42.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $42.5 million in Q4 2025 to a low of $5.8 million in Q1 2024.
• Historically, Revenue has averaged $11.6 million across 4 years, with a median of $8.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Revenue surged 477.26% in 2025, then declined 12.8% in 2026.
• A 4-year view of Revenue shows it stood at $7.2 million in 2023, then advanced by 2.71% to $7.4 million in 2024, then soared by 477.26% to $42.5 million in 2025, then tumbled by 80.66% to $8.2 million in 2026.
• The last three Revenue figures came in at $8.2 million (Q1 2026), $42.5 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.